U.S. Biotech Stock News

Allison Transmission Holdings: recent performance snapshot Allison Transmission Holdings (ALSN) has drawn attention after a recent pullback, with the stock showing a 4.2% decline over the past month even as the past 3 months remain positive. See our latest analysis for Allison Transmission Holdings. At a latest share price of US$112.82, Allison Transmission Holdings has cooled off in the past month but still sits on solid momentum, with a 14.3% 90 day share price return and very strong 3 and...

Wondering if Agree Realty at around US$79.20 is offering fair value or a potential bargain? This article focuses squarely on what the current price might imply about the stock. The share price shows mixed recent returns, with a 2.3% decline over the last 7 days, a 1.4% gain over 30 days, and returns of 9.8% year to date, 7.0% over 1 year, 31.6% over 3 years, and 48.2% over 5 years. These moves are set against ongoing interest in high quality real estate investment trusts, where income...

With no single headline event driving attention to Sealed Air (SEE), investors are instead looking at the packaging company’s fundamentals, including US$5,359.8m in revenue and US$441.2m in net income, to reassess the stock. See our latest analysis for Sealed Air. At a share price of US$41.84, Sealed Air’s short term share price returns have been fairly muted, while the 1 year total shareholder return of 41.67% points to stronger momentum over a longer horizon. If Sealed Air’s mix of...

In recent days, Sezzle Inc. participated in the Wolfe Research FinTech Forum in New York and an Oppenheimer non-deal roadshow, reinforcing its visibility within the fintech and buy-now-pay-later landscape. These appearances come shortly after industry-wide concerns triggered by JPMorgan Chase’s decision to restrict lending to private credit providers, which has weighed on sentiment toward companies like Sezzle. We’ll now explore how JPMorgan’s lending restrictions to private credit providers...

Why MBX Biosciences is on investors’ radar today MBX Biosciences (MBX) has attracted attention after a recent move in its share price, with the stock now around $28 following mixed short term returns, including a decline over the past month and a modest gain over the past 3 months. See our latest analysis for MBX Biosciences. That recent pullback, with a 30 day share price return of around 26% decline and year to date share price return of around 8% decline, contrasts sharply with a very...

Earlier in March 2026, Septerna, Inc. filed an omnibus shelf registration covering common and preferred stock, debt securities, warrants and units, alongside a separate ESOP-related shelf for 3,109,715 common shares valued at about US$89.50 million. The company also reported full-year 2025 results, with sales increasing to US$45.95 million and net loss narrowing to US$48.88 million, while simultaneously announcing a US$150 million at-the-market follow-on equity offering that could materially...

Vera Therapeutics (VERA) is back on investors’ radar after Deerfield Management Company added 418,538 shares in the fourth quarter, as the market watches an FDA priority review decision for lead drug candidate atacicept. See our latest analysis for Vera Therapeutics. At a share price of $39.96, Vera’s recent 7 day share price return of 2.54% sits against a 30 day share price return decline of 5.35% and a 90 day share price return decline of 17.27%. The 1 year total shareholder return of...

Earlier in March 2026, AllianceBernstein Holding reported that preliminary assets under management rose to US$880 billion in February from US$875 billion in January, mainly due to market appreciation despite modest net outflows. The firm also reported that private markets assets under management reached US$82 billion, a year-over-year increase described as 18%, alongside more than US$140 billion in annual sales even as active equities saw net outflows. We’ll now consider how this fresh...

Recent performance snapshot for W.W. Grainger (GWW) W.W. Grainger (GWW) has seen its share price move lower over the past week and month, with returns of around 1% over 1 day, 4% over 7 days, and 5% over the past month. Even with that pullback, the stock still shows positive performance in the past 3 months and over longer periods, including year to date, 1 year, 3 year, and 5 year total returns. See our latest analysis for W.W. Grainger. The recent 1 month share price return of a 5.08%...

Why Citizens Financial Group Is On Investors’ Radar Citizens Financial Group (CFG) has attracted attention after a roughly 14% decline over the past month, prompting investors to reassess the bank’s US$55.64 share price against its recent financial profile. See our latest analysis for Citizens Financial Group. That recent 14% one month share price decline sits against a 41.15% one year total shareholder return and a 101.79% three year total shareholder return, so recent momentum looks weaker...

Why Datadog’s MCP Server Launch Matters for Investors Datadog (DDOG) has put its MCP Server into general availability, giving AI agents governed access to live observability data so they can support automated incident response and real-time production debugging. For shareholders, this launch ties Datadog’s core observability platform more tightly to AI driven workflows, an area attracting significant enterprise spending and growing interest in tools that connect coding agents directly to...

Event-driven snapshot of CBIZ CBIZ (CBZ) is on investors’ radar after recent share price volatility, with the stock showing negative returns over the past month and past 3 months, prompting fresh interest in how its fundamentals line up. See our latest analysis for CBIZ. At a share price of $26.12, CBIZ has seen momentum fade, with a 30 day share price return of 6.18% and a year to date share price return decline of 48.58%, contributing to a 63.27% drop in 1 year total shareholder return. If...

Infleqtion stock at a glance Infleqtion (INFQ) has drawn investor attention after a period of weaker recent returns, with the share price down 5.6% over the past day and 26.2% over the past month. See our latest analysis for Infleqtion. The recent 41.2% year-to-date share price return decline, including a 26.2% drop in the last 30 days, suggests momentum has been fading as investors reassess Infleqtion's risk and growth profile in quantum computing. If Infleqtion's recent swings have you...

Willis Lease Finance (WLFC) just reported record Q4 and full year 2025 revenues, while also launching its Willis Aviation Capital platform with major partnership funding from Liberty Mutual and Blackstone to expand its aviation asset management reach. See our latest analysis for Willis Lease Finance. Despite the record 2025 revenues and the launch of Willis Aviation Capital with Liberty Mutual and Blackstone, the share price has cooled recently. The 1 month share price return shows a 16.0%...

In early March 2026, Bath & Body Works reported that fourth-quarter sales slipped to US$2,724 million and net income to US$403 million, with full-year earnings per share from continuing operations easing to US$3.11 as it guided to lower 2026 sales and earnings. At the same time, the company completed a US$382.85 million buyback program, repurchasing 14,638,891 shares, while outlining plans to scale back promotional discounting and reposition the brand through product innovation and...

In March 2026, Sensata Technologies announced its FaultBreak contactor, a next-generation high voltage switching and protection solution for electric vehicles, combining passive and resettable fuse functions to improve fault clearing, safety, and system simplicity. By merging fuse and contactor functions into a compact, resettable device that cuts component count by over half, FaultBreak aims to help automakers reduce system cost, weight, and complexity while enhancing EV safety and...

Li Auto Inc. recently reported fourth-quarter 2025 results showing revenue falling to CNY 28,775.42 million and net income dropping to CNY 6.52 million, alongside guidance for first-quarter 2026 that points to lower deliveries and total revenue year over year. At the same time, the company is reshaping its governance to meet updated Hong Kong Listing Rules, while betting heavily on new flagship models, artificial intelligence, and overseas expansion in 2026 to revive its weakened business...

Apellis Pharmaceuticals recently added Mikael Dolsten, M.D., Ph.D., former chief scientific officer of Pfizer, to its board of directors, bringing decades of high-level research and development leadership across major global drug makers. This appointment, alongside growing analyst interest in Apellis’s key products Empaveli and Syfovre, underscores how external experts view the company’s pipeline and commercial portfolio as increasingly relevant in rare kidney disease and eye care...

Copa Holdings recently reported that rising operating costs have compressed margins even as passenger and cargo demand increased and the airline continued modernizing and expanding its fleet toward an expected 133 aircraft by the end of 2026. Management’s guidance for a 2026 operating margin range and analysts’ more optimistic earnings estimates together highlight a tension between cost pressures and confidence in the business’s ability to sustain profitability. We’ll now examine how rising...

Expeditors International of Washington recently reported Q4 2025 results with earnings per share of US$1.49 and revenue of US$2.86 billion, both ahead of analyst forecasts despite year-on-year declines. The board also approved a new share repurchase program of up to US$3.00 billion, highlighting management’s willingness to return substantial capital to shareholders. Next, we’ll examine how the stronger-than-expected quarterly earnings reshape Expeditors International of Washington’s...

In early March 2026, Akamai Technologies disclosed a four-year, US$200 million AI services agreement with a major U.S. tech company and detailed plans to deploy one of the world’s largest NVIDIA Blackwell RTX PRO 6000 Server Edition GPU clusters on its distributed cloud platform. On the same day, Akamai also urged shareholders to vote against a proposal for expanded political spending disclosures, highlighting an internal debate over how transparently the company reports its use of corporate...

In March 2026, Omnes Capital, a European private equity firm focused on the energy transition with more than €6.70 billion in assets under management, announced it is adopting Intapp’s DealCloud platform for marketing and investor relations to centralize fundraising and relationship management. The decision highlights how Intapp’s AI-powered automation and data-integration capabilities are being used to cut manual data entry and provide real-time relationship and market insights for...

In March 2026, National Fuel Gas’s board approved a regular quarterly dividend of US$0.535 per share, payable on April 15, 2026, to shareholders of record as of March 31, 2026, with about 95.0 million common shares and no preferred stock outstanding. Alongside this dividend affirmation, shareholders backed all management proposals at the 2026 annual meeting, reinforcing confidence in the company’s governance, audit oversight, and long-running record of uninterrupted annual dividend...

Vail Resorts recently reported that second-quarter fiscal 2026 revenue fell to US$1,083.93 million and net income to US$210.01 million, lowered full-year earnings guidance, and still affirmed a US$2.22 per-share quarterly dividend, while also signaling interest in pursuing new acquisition opportunities. At the same time, historically low snowfall and renewed public pressure from Matthew Prince to buy Park City Mountain Resort have sharpened attention on how Vail Resorts balances its...